1. Home
  2. ECOR vs INUV Comparison

ECOR vs INUV Comparison

Compare ECOR & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.10

Market Cap

50.0M

Sector

Health Care

ML Signal

HOLD

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$2.53

Market Cap

47.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECOR
INUV
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
47.2M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ECOR
INUV
Price
$6.10
$2.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$22.00
$12.67
AVG Volume (30 Days)
46.9K
339.2K
Earning Date
01-01-0001
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
53.51
50.00
EPS
N/A
N/A
Revenue
$25,182,000.00
$86,209,305.00
Revenue This Year
$28.92
$12.82
Revenue Next Year
$32.50
$4.23
P/E Ratio
N/A
N/A
Revenue Growth
57.09
2.88
52 Week Low
$4.16
$0.28
52 Week High
$9.22
$6.27

Technical Indicators

Market Signals
Indicator
ECOR
INUV
Relative Strength Index (RSI) 42.70 51.61
Support Level $4.64 $2.39
Resistance Level $8.02 $3.64
Average True Range (ATR) 0.71 0.34
MACD -0.16 0.03
Stochastic Oscillator 5.42 43.35

Price Performance

Historical Comparison
ECOR
INUV

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: